urinary tract infection
Medications
Instructed in new medication Starlix to manage diabetes. In addition, warned of possible S/E such as dizziness, diarrhea, hypoglycemia, back pain, arthropathy, upper respiratory tractinfection, bronchitis, coughing, flu symptoms and accidental trauma. Instructed to take drug 1 to 30 minutes before a meal. Notify MD for persistent hypoglycemia or hyperglycemia.
Instructed in new medication Glucovance to improve glycemic control in patients with type-two diabetes whose hyperglycemia cannot be controlled with diet and exercise alone. In addition, warned of possible S/E such as headache, dizziness, diarrhea, nausea, vomiting, abdominal pain, hypoglycemia, lactic acidosis, or upper respiratory tractinfection. Instructed to take one daily with breakfast and, if twice daily, then at breakfast and dinner. Stop drug and tell prescriber of unexplained hyperventilation, myalgia, malaise, unusual somnolence, or other symptoms of early lactic acidosis. GI symptoms are common with initial drug therapy but GI symptoms that occur after prolonged therapy may be related to lactic acidosis or other serious disease and should be reported promptly. Instructed not to take any other drugs, including OTC drugs, without checking with prescriber.
Instructed patient on new medication Ciprofloxacin HCL, which is used to manage tractinfection. In addition, warned of possible S/E, such as, headache, restlessness, tremor, dizziness, fatigue, drowsiness, insomnia, depression, light-headedness, confusion, hallucinations, seizures, paresthesia, thrombophlebitis, edema, nausea, diarrhea, vomiting, abdominal pain or discomfort, oral candidiasis, pseudomembranous colitis, dyspepsia, flatulence, constipation, crystalluria, interstitial nephritis, eosinophilia, leukopenia, neutropenia, thrombocytopenia, arthralgia, arthropathy, joint or back pain, joint inflammation, joint stiffness, tendon rupture, aching, neck or chest pain, rash, photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, burning, pruritus, erythema, hyperpigmentation.
SN instructed patient / caregiver that Advair Diskus is a combination of inhaled drugs that is used to treat asthma and chronic bronchitis. SN instructed patient / caregiver on common side effects including upper respiratory tractinfection & headaches. SN instructed to call physician / nurse for adverse effects including nausea, vomiting, diarrhea, mouth or throat candidiasis, or musculoskeletal pain.
SN instructed about Pantoprazole or Protonix , it is used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. Pantoprazole may also be used in combination with antibiotics to treat ulcers caused by helicobacter pylori. Possible side effect / adverse reaction may include, Infection: Stomach acid plays a role in killing ingested bacteria. Use of pantoprazole may increase the chance of developing infections such as pneumonia, particularly in hospitalized patients. Gastrointestinal: abdominal pain , diarrhea , flatulence. Neurologic: headache. Serious side effect : Gastrointestinal: atrophic gastritis, clostridium difficile diarrhea; Hematologic: thrombocytopenia; Immunologic: Stevens-Johnson syndrome, toxic epidermal necrolysis; Musculoskeletal: Muscle disorders, bone fracture and infection, clostridium difficile infection, osteoporosis-related hip fracture, rhabdomyolysis; Renal: interstitial nephritis (rare), Nutrition: may reduce the absorption of important nutrients, vitamins and minerals, as well as medications.
SN instructed patient on medication Sofosbuvir. Is used with other antiviral medications ( such as ribavirin, peginterferon, daclatasvir ) to treat chronic ( long-lasting ) hepatitis C, a viral infection of the liver. It works by reducing the amount of hepatitis C virus in your body, which may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring ( cirrhosis ), or liver cancer.Sofosbuvir in combination with other antiviral medications reduces the amount of hepatitis C virus in the body and helps the body's immune system fight the infection. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" ( including the use of latex condoms ) to lower the risk of passing the virus to others.Fairly understood the teaching.
SN instructed patient on medication Daclatasvir is used with another antiviral medication ( sofosbuvir ) to treat chronic ( long-lasting ) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication ( ribavirin ). These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" ( including the use of latex condoms ) to lower the risk of passing the virus to others. Patient fairly understood the teachings.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.
SN advised patient on some serious adverse effects of gentamycin such as: neuromuscular blockade finding, ototoxicity, nephrotoxicity, respiratory tract paralysis, concomitant anesthesia, and muscle relaxants.
Instructed in new medication Calcium and in S/E such as headache, weakness, dizziness, paresthesia, chest pressure, facial flushing, edema of feet, eye pain, nasal congestion, transient nausea, unusual taste, diarrhea, anorexia, vomiting, epigastric discomfort, abdominal pain, increased urinary frequency, nocturia, shortness of breath, rash, pruritus of ear lobes, inflammation at injection site, hypersensitivity reactions (anaphylaxis), chills and tender palms and soles.